Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
ASSETS
Cash and cash equivalents	$ 34,005	$ 4,079
Marketable securities	46,516	4,157
Securities owned	9,756	1,616
Receivable from clearing brokers	3,995	17,279
Long-term equity investments	11,744	12,282
Loans to employees	1,767	2,150
Right-of-use assets	2,721	2,944
Notes receivable		902
Prepaid expenses and other assets	2,403	1,716
Total assets	112,907	47,125
LIABILITIES AND STOCKHOLDERS’ EQUITY
Accounts payable and accrued expenses	611	919
Accrued compensation and commissions	17,754	2,057
Accrued dividends payable	10,335
Contract liabilities	4,504	1,100
Lease liability	2,841	3,039
Income taxes payable	7,318
Other liabilities	173	157
Total liabilities	43,536	7,272
Stockholders’ equity
Preferred stock, value
Common stock, $0.0001 par value, 100,000,000 shares authorized; 16,067,435 and 7,037,022 shares issued as of December 31, 2025 and 2024, respectively; 16,067,435 and 6,976,874 shares outstanding as of December 31, 2025 and 2024, respectively
Additional paid-in capital	337,505	263,820
Treasury stock, as of cost, 0 shares and 60,148 shares as of December 31, 2025 and 2024, respectively		(501)
Accumulated deficit	(268,134)	(223,466)
Total stockholders’ equity	69,371	39,853
Total liabilities and stockholders’ equity	112,907	47,125
Series D Convertible Preferred Stock
Stockholders’ equity
Preferred stock, value
Series D-1 Convertible Preferred Stock
Stockholders’ equity
Preferred stock, value